Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Major Pan-European report highlights stark inequalities in cancer treatment throughout Europe

07.10.2005


A report by the Karolinska Institutet, in conjunction with the Stockholm School of Economics, exposes stark inequalities in patient access to cancer treatment across Europe and urges action by decision makers to redress these inequalities.



The report, entitled ‘A pan-European comparison regarding patient access to cancer drugs’, found that despite the proven benefits of new innovative treatments options, patients across Europe do not have equality of access to these cancer drugs and the speed at which patients can benefit from them depends to a great extent upon the country in which they live.

Nineteen countries, representing almost 75% of Europe’s population, were included in the report. Austria, Spain, and Switzerland are shown to be the leaders in terms of early adoption and availability of new cancer drugs whereas other countries, such as the UK, Czech Republic, Hungary Norway, and Poland lag behind.


“Patients have to wait too long to obtain the benefits of newer therapies and the biggest hurdle to the uptake of new drugs is the proactive allocation of financial resources and budget in the health care systems by policy and decision makers”, says Dr. Nils Wilking of the Karolinska Institutet.

Drs Wilking and Jönsson point out that the total healthcare cost for cancer in countries included in this report is an estimated 120 euros per citizen – only 5% of total healthcare expenditure. The cost of cancer drugs per capita ranges from 7 euros to 16 euros per citizen in Europe. Costs associated with inpatient hospital care costs dominate the direct costs of cancer in Europe, accounting for 60% to 94% of all costs and less than 10% is spent on drugs. The share of health care costs for cancer is much less than the share of burden of the disease.

“A superior approach for cancer patients in Europe would be to take a broader perspective on the benefits and costs these drugs bring to patients and society, and introduce a more rational system of allocation of resources to the healthcare system,” explained Dr. Bengt Jönsson of the Stockholm School of Economics. “It is worth emphasising that new treatments are usually targeted to specifically identifiable populations” ‘he continued. Dr Jönsson also added “There are examples of best practice in some countries which try to expedite patient access to innovative therapies - these should be assessed on their applicability for more countries in Europe.”

The report also argues that while new therapies generally increase health expenditure, the value they bring to patients in terms of survival and treating their cancer must be recognized. Research undertaken in the U.S. by Dr. Frank Lichtenberg of Columbia University suggests that access to more and newer cancer drugs improves survival rates.

For further information, please contact:
Nils Wilking, mobile +46 73 625 17 19, e-mail: nils.wilking@telia.com

Bengt Jönsson, mobile +46 70 847 03 63, e-mail Bengt.Jonsson@hhs.se

Sabina Bossi | alfa
Further information:
http://info.ki.se/new_uploads/Cancer%20Report(1).pdf
http://www.ki.se

More articles from Health and Medicine:

nachricht The end of pneumonia? New vaccine offers hope
23.10.2017 | University at Buffalo

nachricht Scientists track ovarian cancers to site of origin: Fallopian tubes
23.10.2017 | Johns Hopkins Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Salmonella as a tumour medication

HZI researchers developed a bacterial strain that can be used in cancer therapy

Salmonellae are dangerous pathogens that enter the body via contaminated food and can cause severe infections. But these bacteria are also known to target...

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

3rd Symposium on Driving Simulation

23.10.2017 | Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

 
Latest News

Microfluidics probe 'cholesterol' of the oil industry

23.10.2017 | Life Sciences

Gamma rays will reach beyond the limits of light

23.10.2017 | Physics and Astronomy

The end of pneumonia? New vaccine offers hope

23.10.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>